Immunogenicity of combination vaccines versus separate vaccines for diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, pneumococcal infections and haemophilus infections in infants

Trial Profile

Immunogenicity of combination vaccines versus separate vaccines for diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, pneumococcal infections and haemophilus infections in infants

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs DTaP vaccine; DTaP-hepatitis B-poliovirus vaccine; Hepatitis B vaccine recombinant; Hib-CRM197 vaccine conjugate; Pneumococcal 7-valent CRM197 vaccine conjugate; Poliovirus vaccine inactivated
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top